Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 18/20 | 0.64 |
| ▸ | PPARA | Q07869 | 2/20 | 0.58 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245343 | 0.91 | PPARD (0.52) | PPARDPPARAPTGDR2FFAR1 | |
| SCHEMBL1245359 | 0.91 | PPARD (0.74) | PPARDPPARAPTGDR2FFAR1PPARG | |
| SCHEMBL1745624 | 0.90 | PPARD (0.72) | PPARDPPARAPTGDR2FFAR1 | |
| SCHEMBL1745627 | 0.90 | PPARD (0.72) | PPARDPPARAPTGDR2FFAR1 | |
| SCHEMBL1246172 | 0.85 | PPARD (0.46) | PPARDPPARAPTGDR2FFAR1PPARG | |
| SCHEMBL1246268 | 0.85 | PPARD (0.57) | PPARDPPARAPTGDR2FFAR1PPARG | |
| SCHEMBL1744435 | 0.85 | PPARD (0.57) | PPARDPPARAPTGDR2FFAR1PPARG | |
| SCHEMBL1745172 | 0.85 | PPARD (0.57) | PPARDPPARAPTGDR2FFAR1PPARG | |
| SCHEMBL1744439 | 0.85 | PPARD (0.57) | PPARDPPARAPTGDR2FFAR1PPARG | |
| SCHEMBL5959565 | 0.83 | PPARD (0.68) | PPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110039841-A1 | Novel compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2011-02-17 | — | — | US | claimed |
| EP-1763511-B1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | HIGH POINT PHARMACEUTICALS LLC (US) | 2010-07-28 | — | — | EP | claimed |
| EP-1763511-A1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | NOVO NORDISK A/S (DK) | 2007-03-21 | — | — | EP | claimed |
| WO-2005105735-A1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | NOVO NORDISK A/S (DK) | 2005-11-10 | — | — | WO | claimed |
| US-20110039841-A1 | Novel compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2011-02-17 | — | — | US | disclosed |
| US-20110039841-A1 | Novel compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2011-02-17 | — | — | US | disclosed |
| EP-1763511-B1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | HIGH POINT PHARMACEUTICALS LLC (US) | 2010-07-28 | — | — | EP | disclosed |
| EP-1763511-A1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | NOVO NORDISK A/S (DK) | 2007-03-21 | — | — | EP | disclosed |
| WO-2005105735-A1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | NOVO NORDISK A/S (DK) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039841-A1 | Novel compounds, their preparation and use | PPARG, PPARD, PPARA | PPARD 2/4885PPARA 3/4885PTGDR2 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.